サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1291348

遺伝子治療市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測

Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
遺伝子治療市場：世界の産業動向、シェア、規模、成長機会、2023-2028年予測
出版日: 2023年05月29日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遺伝子治療市場規模は、2022年に44億米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に15.39%の成長率（CAGR）を示し、2028年までに109億米ドルに達すると予測しています。遺伝性疾患や後天性疾患の増加、病院、診療所、介護施設の建設増加、オピオイドに代わる安全で中毒性のない新しい遺伝子治療の人気の高まりなどが、市場を牽引する主な要因の一部です。

慢性疾患の増加による市場成長への影響

大衆の間で様々な慢性疾患の有病率が高まっていることは、遺伝子治療市場の成長を促進する重要な要因の1つです。また、不健康な生活習慣の採用による心血管合併症、糖尿病、甲状腺炎、肥満などの慢性疾患の発生が、市場の成長に寄与しています。さらに、大衆の間でがんの症例が増加しており、効果的な腫瘍学的治療に対する需要の高まりとともに、良好な市場展望を提供しています。さらに、過度の喫煙習慣による慢性肺疾患の増加も、遺伝子治療市場の成長を後押ししています。

市場構造、主要企業による市場シェア、プレイヤーのポジショニング、主要成功戦略、競合ダッシュボード、企業評価象限などの競合分析については、本レポートで取り上げています。また、すべての主要企業の詳細なプロファイルが提供されています。遺伝子治療市場の構造は、多数の世界的および地域的なプレーヤーが存在するため、適度に断片化されています。高い資本投資が必要であること、政府の政策が厳しいこと、製品の差別化率が低いことなどから、市場への新規参入の量は中程度です。

遺伝子治療とは？

遺伝子治療とは、治療目的で変異した遺伝子の発現を変化させたり、生体細胞の生物学的特性を変化させたりすることで、病気の進行を防ぐ技術です。ウイルスベクター、細菌ベクター、プラスミド・デオキシリボ核酸（DNA）、ヒト遺伝子編集技術、患者由来の細胞性遺伝子治療など、さまざまな製品から構成されています。遺伝性疾患の原因となっている変異を修復するために、健康な遺伝子を個人のゲノムに導入するものです。生体外遺伝子治療、生体内遺伝子治療、in situ遺伝子治療など、さまざまな治療法からなります。遺伝子治療は、遺伝子の抑制、遺伝子の増強、そして最終的には病気の原因となる細胞の死滅によって機能します。薬では防げない特定の病気を治すことができ、病気の症状を永久に取り除くことができる可能性があります。また、がん、糖尿病、血友病、嚢胞性線維症、心臓病、後天性免疫不全症候群（AIDS）など、さまざまな病気に対する体の抵抗力を向上させることができます。また、遺伝子治療は他の薬のように何度も服用する必要がないため、世界中でその需要が高まっています。

COVID-19の影響：

コロナウイルスの発生は、遺伝子治療市場を大きく混乱させ、さまざまなバイオ医薬品企業の業績に影響を与えました。一部の遺伝子治療企業は、その複雑な製造・送達システムや資金調達モデルにより、膨大な数の合併症に直面しました。治療の製造と提供、研究開発と臨床開発、商業運営はパンデミックによって悪影響を受け、その結果、遺伝子治療市場の成長が阻害されました。また、遺伝子治療製品の製造・開発を支えるサプライチェーンは、管理された複雑な環境を必要とします。サプライチェーンは、施錠や道路を介した移動に課された制限によって深刻な影響を受けました。さらに、COVID-19の発生により、いくつかの企業が業務の遅延や完全停止を報告しました。

遺伝子治療の市場動向：

現在、遺伝子治療は、生命を脅かすさまざまな難病の治療に有効であることから、その需要が高まっており、市場にプラスの影響を与える主要な要因の一つとなっています。これに加えて、大衆の間で遺伝性疾患や後天性疾患の有病率が上昇していることも、市場の成長を後押ししています。また、患者に質の高いヘルスケアサービスを提供するために、世界中で病院、診療所、介護施設の建設が増加していることも、市場の成長に寄与しています。これとは別に、腰痛や稀な神経障害性疼痛障害など、幅広い慢性疼痛疾患の治療において、オピオイドに代わるより安全で非中毒性のものを提供する新しい遺伝子治療の人気が高まっており、市場の好ましい展望を提供しています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者について
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 遺伝子治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19のインパクト
  • 市場予測

第6章 遺伝子タイプ別市場内訳

  • 抗原
    • 市場動向
    • 市場予測
  • サイトカイン
    • 市場動向
    • 市場予測
  • 腫瘍抑制剤
    • 市場動向
    • 市場予測
  • 自殺遺伝子
    • 市場動向
    • 市場予測
  • 欠損症
    • 市場動向
    • 市場予測
  • 成長因子
    • 市場動向
    • 市場予測
  • レセプター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 ベクタータイプ別市場内訳

  • ウイルスベクター
    • 市場動向
    • 主要セグメント
      • アデノウイルス
      • レンチウイルス
      • レトロウイルス
      • アデノ随伴ウイルス
      • 単純ヘルペスウイルス
      • ポックスウイルス
      • ワクシニアウイルス
      • その他
    • 市場予測
  • 非ウイルス技術
    • 市場動向
    • 主要セグメント
      • ネイキッドベクターとプラスミドベクター
      • ジーンガン
      • エレクトロポレーション
      • リポフェクション
      • その他
    • 市場予測

第8章 送達方法別市場内訳

  • インビボジーンセラピー
    • 市場動向
    • 市場予測
  • エクスビボジーンセラピー
    • 市場動向
    • 市場予測

第9章 アプリケーション別市場内訳

  • オンコロジー疾患
    • 市場動向
    • 市場予測
  • 希少疾患
    • 市場動向
    • 市場予測
  • 循環器系疾患
    • 市場動向
    • 市場予測
  • 神経系疾患
    • 市場動向
    • 市場予測
  • 感染症
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会（Opportunities
  • 脅威（Treats

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abeona Therapeutics Inc.
    • Adaptimmune Therapeutics plc
    • Adverum Biotechnologies Inc.
    • Amgen Inc.
    • Astellas Pharma Inc.
    • Biogen Inc.
    • Bluebird Bio Inc.
    • Mustang Bio Inc.（Fortress Biotech Inc.）
    • Novartis AG
    • Orchard Therapeutics plc
    • UniQure N.V.
    • Voyager Therapeutics Inc.
図表

List of Figures

  • Figure 1: Global: Gene Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Gene Therapy Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Gene Therapy Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Gene Therapy Market: Breakup by Gene Type (in %), 2022
  • Figure 5: Global: Gene Therapy Market: Breakup by Vector Type (in %), 2022
  • Figure 6: Global: Gene Therapy Market: Breakup by Delivery Method (in %), 2022
  • Figure 7: Global: Gene Therapy Market: Breakup by Application (in %), 2022
  • Figure 8: Global: Gene Therapy Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Gene Therapy (Antigen) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Gene Therapy (Antigen) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Gene Therapy (Cytokine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Gene Therapy (Cytokine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Gene Therapy (Tumor Suppressor) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Gene Therapy (Tumor Suppressor) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Gene Therapy (Suicide Gene) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Gene Therapy (Suicide Gene) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Gene Therapy (Deficiency) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Gene Therapy (Deficiency) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Gene Therapy (Growth Factors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Gene Therapy (Growth Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Gene Therapy (Receptors) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Gene Therapy (Receptors) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Gene Therapy (Other Gene Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Gene Therapy (Other Gene Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Gene Therapy (Viral Vector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Gene Therapy (Viral Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Gene Therapy (Non-Viral Techniques) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Gene Therapy (Non-Viral Techniques) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Gene Therapy (In-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Gene Therapy (In-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Gene Therapy (Ex-Vivo Gene Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Gene Therapy (Oncological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Gene Therapy (Oncological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Gene Therapy (Rare Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Gene Therapy (Rare Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Global: Gene Therapy (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Global: Gene Therapy (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: Global: Gene Therapy (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: Global: Gene Therapy (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Global: Gene Therapy (Infectious Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Global: Gene Therapy (Infectious Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Global: Gene Therapy (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Global: Gene Therapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: North America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: North America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: United States: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: United States: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Canada: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Canada: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Asia-Pacific: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Asia-Pacific: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: China: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: China: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Japan: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Japan: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: India: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: India: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: South Korea: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: South Korea: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Australia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Australia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Indonesia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Indonesia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Europe: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Europe: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Germany: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Germany: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: France: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: France: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: United Kingdom: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: United Kingdom: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Italy: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Italy: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Spain: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Spain: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Russia: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Russia: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Latin America: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Latin America: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Brazil: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 86: Brazil: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Mexico: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 88: Mexico: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Others: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 90: Others: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 91: Middle East and Africa: Gene Therapy Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 92: Middle East and Africa: Gene Therapy Market: Breakup by Country (in %), 2022
  • Figure 93: Middle East and Africa: Gene Therapy Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Global: Gene Therapy Industry: SWOT Analysis
  • Figure 95: Global: Gene Therapy Industry: Value Chain Analysis
  • Figure 96: Global: Gene Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Gene Therapy Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Gene Therapy Market Forecast: Breakup by Gene Type (in Million US$), 2023-2028
  • Table 3: Global: Gene Therapy Market Forecast: Breakup by Vector Type (in Million US$), 2023-2028
  • Table 4: Global: Gene Therapy Market Forecast: Breakup by Delivery Method (in Million US$), 2023-2028
  • Table 5: Global: Gene Therapy Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Gene Therapy Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Gene Therapy Market: Competitive Structure
  • Table 8: Global: Gene Therapy Market: Key Players
目次
Product Code: SR112023A5026

The global gene therapy market size reached US$ 4.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 15.39% during 2023-2028. The growing prevalence of inherited diseases and acquired disorders; increasing construction of hospitals, clinics, and nursing homes; and rising popularity of new gene therapy that offers a safer, non-addictive alternative to opioids represent some of the key factors driving the market.

Rising Occurrence of Chronic Diseases Augmenting Market Growth

The increasing prevalence of various chronic diseases among the masses represents one of the key factors propelling the growth of the gene therapy market. Besides this, the occurrence of various chronic diseases, such as cardiovascular complications, diabetes, thyroiditis, and obesity, due to the adoption of unhealthy lifestyle patterns is contributing to the growth of the market. Moreover, rising cases of cancer among the masses, along with the growing demand for effective oncology treatment, is offering a favorable market outlook. Furthermore, the increasing occurrence of chronic lung diseases due to excessive smoking habits is bolstering the growth of the gene therapy market.

Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. The structure of the gene therapy market is moderately fragmented due to the presence of a large number of global and regional players. The volume of new entrants in the market is moderate due to the requirement for high capital investments, stringent government policies, and the rate of product differentiation is low.

What is Gene Therapy?

Gene therapy is a technique for preventing disease progression by modifying the expression of mutated genes or altering the biological properties of living cells for therapeutic use. It comprises different products, such as viral vectors, bacterial vectors, plasmid deoxyribonucleic acid (DNA), human gene-editing technology, and patient-derived cellular gene therapy. It involves the introduction of a healthy gene into the genome of an individual to repair a mutation that is causing a genetic disorder. It consists of various therapies, such as ex vivo, in vivo, and in situ gene therapy. Gene therapy functions via gene inhibition, gene augmentation, and ultimately killing the disease-causing cells. It can cure certain diseases which no medications can prevent and has the potential to get rid of disease symptoms permanently. It also improves the ability of the body to fight against a wide variety of diseases, such as cancer, diabetes, hemophilia, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome (AIDS). Furthermore, as gene therapy does not require multiple doses like other medications, its demand is increasing around the world.

COVID-19 Impact:

The outbreak of coronavirus severely disrupted the gene therapy market and affected the performance of various biopharmaceutical companies. Some gene therapy companies faced an immense number of complications due to their complicated manufacturing and delivery systems and funding models. The manufacture and delivery of treatment, research and clinical development, and commercial operations were negatively impacted by the pandemic, which resulted in a disruption in the growth of the gene therapy market. In addition, the supply chains that support the manufacturing and development of gene therapy products require controlled and complex settings. The supply chain was severely impacted by lockdowns and restrictions imposed on movement via roads. Furthermore, several companies reported delays or complete halts in operations due to the outbreak of COVID-19.

Gene Therapy Market Trends:

At present, the growing demand for gene therapy, as it is effective in curing various critical and life-threatening diseases, represents one of the primary factors influencing the market positively. Besides this, the rising prevalence of inherited diseases and acquired disorders among the masses is propelling the growth of the market. In addition, the increasing construction of hospitals, clinics, and nursing homes around the world to provide quality healthcare services to patients is contributing to the growth of the market. Apart from this, the rising popularity of new gene therapy that offers a safer and non-addictive alternative to opioids in treating a broad range of chronic pain conditions, such as lower back pain and rare neuropathic pain disorders, is offering a favorable market outlook.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global gene therapy market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on gene type, vector type, delivery method and application.

Gene Type Insights:

Antigen

Cytokine

Tumor Suppressor

Suicide Gene

Deficiency

Growth Factors

Receptors

Others

The report has provided a detailed breakup and analysis of the gene therapy market based on the gene type. This includes antigen, cytokine, tumor suppressor, suicide gene, deficiency, growth factors, receptors, and others.

Vector Type Insights:

Viral Vector

Adenoviruses

Lentiviruses

Retroviruses

Adeno-Associated Virus

Herpes Simplex Virus

Poxvirus

Vaccinia Virus

Others

Non-Viral Techniques

Naked and Plasmid Vectors

Gene Gun

Electroporation

Lipofection

Others

A detailed breakup and analysis of the gene therapy market based on the vector type has also been provided in the report. This includes viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) and non-viral techniques (naked and plasmid vectors, gene gun, electroporation, lipofection, and others). According to the report, viral vector (adenoviruses, lentiviruses, retroviruses, adeno-associated virus, herpes simplex virus, poxvirus, vaccinia virus, and others) accounted for the largest market share as it is highly efficient in mitigating the impacts of infectious diseases and viruses. In addition, the rising utilization of viral vectors as they are easy to handle and modify is propelling the growth of the respective segment.

Delivery Method Insights:

In-Vivo Gene Therapy

Ex-Vivo Gene Therapy

A detailed breakup and analysis of the gene therapy market based on the delivery method has also been provided in the report. This includes in-vivo gene therapy and ex-vivo gene therapy.

Application Insights:

Oncological Disorders

Rare Diseases

Cardiovascular Diseases

Neurological Disorders

Infectious Disease

Others

A detailed breakup and analysis of the gene therapy market based on the application has also been provided in the report. This includes oncological disorders, rare diseases, cardiovascular diseases, neurological disorders, infectious disease, and others. According to the report, oncological disorders accounted for the largest market share due to increasing occurrence of cancer among the masses. Apart from this, the rising employment of gene therapy in cancer treatment as it provides remarkable efficacy is bolstering the growth of the market.

Regional Insights:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for gene therapy. Some of the factors driving the North America gene therapy market included the rising awareness about the benefits of gene therapy in treating various chronic diseases and the increasing expenditure in research and development (R&D) activities to develop effective gene therapies is propelling the market growth. In addition, the growing construction of various healthcare facilities to provide quality treatment to patients is propelling the growth of the market.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global gene therapy market. Some of the companies covered in the report include:

Abeona Therapeutics Inc.

Adaptimmune Therapeutics plc

Adverum Biotechnologies Inc.

Amgen Inc.

Astellas Pharma Inc.

Biogen Inc.

Bluebird Bio Inc.

Mustang Bio Inc. (Fortress Biotech Inc.)

Novartis AG

Orchard Therapeutics plc

UniQure N.V.

Voyager Therapeutics Inc.

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. What was the size of the global gene therapy market in 2022?

2. What is the expected growth rate of the global gene therapy market during 2023-2028?

3. What are the key factors driving the global gene therapy market?

4. What has been the impact of COVID-19 on the global gene therapy market?

5. What is the breakup of the global gene therapy market based on the vector type?

6. What is the breakup of the global gene therapy market based on the application?

7. What are the key regions in the global gene therapy market?

8. Who are the key players/companies in the global gene therapy market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Gene Therapy Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Gene Type

  • 6.1  Antigen
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Cytokine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Tumor Suppressor
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Suicide Gene
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Deficiency
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Growth Factors
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Receptors
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8  Others
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7   Market Breakup by Vector Type

  • 7.1  Viral Vector
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Adenoviruses
      • 7.1.2.2 Lentiviruses
      • 7.1.2.3 Retroviruses
      • 7.1.2.4 Adeno-Associated Virus
      • 7.1.2.5 Herpes Simplex Virus
      • 7.1.2.6 Poxvirus
      • 7.1.2.7 Vaccinia Virus
      • 7.1.2.8 Others
    • 7.1.3 Market Forecast
  • 7.2  Non-Viral Techniques
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Naked and Plasmid Vectors
      • 7.2.2.2 Gene Gun
      • 7.2.2.3 Electroporation
      • 7.2.2.4 Lipofection
      • 7.2.2.5 Others
    • 7.2.3 Market Forecast

8   Market Breakup by Delivery Method

  • 8.1  In-Vivo Gene Therapy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Ex-Vivo Gene Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9   Market Breakup by Application

  • 9.1  Oncological Disorders
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2  Rare Diseases
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3  Cardiovascular Diseases
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4  Neurological Disorders
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5  Infectious Disease
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6  Others
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast

10  Market Breakup by Region

  • 10.1  North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2  Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3  Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4  Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5  Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11  SWOT Analysis

  • 11.1  Overview
  • 11.2  Strengths
  • 11.3  Weaknesses
  • 11.4  Opportunities
  • 11.5  Threats

12  Value Chain Analysis

13  Porters Five Forces Analysis

  • 13.1  Overview
  • 13.2  Bargaining Power of Buyers
  • 13.3  Bargaining Power of Suppliers
  • 13.4  Degree of Competition
  • 13.5  Threat of New Entrants
  • 13.6  Threat of Substitutes

14  Price Analysis

15  Competitive Landscape

  • 15.1  Market Structure
  • 15.2  Key Players
  • 15.3  Profiles of Key Players
    • 15.3.1  Abeona Therapeutics Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2  Adaptimmune Therapeutics plc
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3  Adverum Biotechnologies Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
    • 15.3.4  Amgen Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5  Astellas Pharma Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6  Biogen Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7  Bluebird Bio Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8  Mustang Bio Inc. (Fortress Biotech Inc.)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9  Novartis AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10  Orchard Therapeutics plc
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11  UniQure N.V.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12  Voyager Therapeutics Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials